Alivus Life Sciences Limited Share Price & Analysis
₹1,098.7▼ -0.01%Updated 13 May 2026, 11:32 am IST
LTP
₹1,098.7
-0.01%
Open
₹—
High
₹1,110
Low
₹1,093.9
Close
₹1,098.7
52W High
—
52W Low
—
Volume
15K
Lot Size
1
Sector
—
Market Cap
—
Face Value
—
Price Chart
About Alivus Life Sciences Limited
Glenmark Life Sciences, a subsidiary of Nirma Limited, a diversified conglomerate with interest in consumer products, cement, chemicals and pharmaceuticals. It is a leading developer and manufacturer of select, high-value, non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas. The company further operates in Contract Development and manufacturing operations to offer services to specialty Pharmaceutical companies.
Related Analysis
Frequently Asked Questions
What is Alivus Life Sciences Limited share price today?▾
Alivus Life Sciences Limited (ALIVUS) is currently trading at ₹1,098.7 on NSE, down 0.01% as of the last market session. Prices update daily after market close on MarketNetra.
Is Alivus Life Sciences Limited available in F&O (Futures & Options)?▾
Yes, Alivus Life Sciences Limited (ALIVUS) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Alivus Life Sciences Limited 52-week high and low?▾
Alivus Life Sciences Limited's 52-week price range is tracked daily on MarketNetra. Check the overview page for the latest 52W high/low figures sourced from NSE.
What is Alivus Life Sciences Limited P/E ratio?▾
Alivus Life Sciences Limited's P/E ratio and other fundamental metrics including P/B, ROE, and ROCE are available on the overview page. Data is sourced weekly from Screener.in.
How to trade Alivus Life Sciences Limited options?▾
Alivus Life Sciences Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade ALIVUS options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.